A citation-based method for searching scientific literature

Toshana L Foster, Harry Wilson, Shilpa S Iyer, Karen Coss, Katie Doores, Sarah Smith, Paul Kellam, Andrés Finzi, Persephone Borrow, Beatrice H Hahn, Stuart J D Neil. Cell Host Microbe 2016
Times Cited: 109







List of co-cited articles
1422 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


IFITM proteins incorporated into HIV-1 virions impair viral fusion and spread.
Alex A Compton, Timothée Bruel, Françoise Porrot, Adeline Mallet, Martin Sachse, Marine Euvrard, Chen Liang, Nicoletta Casartelli, Olivier Schwartz. Cell Host Microbe 2014
125
41

The IFITM proteins inhibit HIV-1 infection.
Jennifer Lu, Qinghua Pan, Liwei Rong, Wei He, Shan-Lu Liu, Chen Liang. J Virol 2011
274
40

IFITM Proteins Restrict HIV-1 Infection by Antagonizing the Envelope Glycoprotein.
Jingyou Yu, Minghua Li, Jordan Wilkins, Shilei Ding, Talia H Swartz, Anthony M Esposito, Yi-Min Zheng, Eric O Freed, Chen Liang, Benjamin K Chen,[...]. Cell Rep 2015
105
36

The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus.
Abraham L Brass, I-Chueh Huang, Yair Benita, Sinu P John, Manoj N Krishnan, Eric M Feeley, Bethany J Ryan, Jessica L Weyer, Louise van der Weyden, Erol Fikrig,[...]. Cell 2009
888
34

IFITM proteins are incorporated onto HIV-1 virion particles and negatively imprint their infectivity.
Kevin Tartour, Romain Appourchaux, Julien Gaillard, Xuan-Nhi Nguyen, Stéphanie Durand, Jocelyn Turpin, Elodie Beaumont, Emmanuelle Roch, Gregory Berger, Renaud Mahieux,[...]. Retrovirology 2014
87
37

Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu.
Stuart J D Neil, Trinity Zang, Paul D Bieniasz. Nature 2008
29

IFITM proteins restrict viral membrane hemifusion.
Kun Li, Ruben M Markosyan, Yi-Min Zheng, Ottavia Golfetto, Brittani Bungart, Minghua Li, Shilei Ding, Yuxian He, Chen Liang, James C Lee,[...]. PLoS Pathog 2013
228
29

Resistance to type 1 interferons is a major determinant of HIV-1 transmission fitness.
Shilpa S Iyer, Frederic Bibollet-Ruche, Scott Sherrill-Mix, Gerald H Learn, Lindsey Plenderleith, Andrew G Smith, Hannah J Barbian, Ronnie M Russell, Marcos V P Gondim, Catherine Y Bahari,[...]. Proc Natl Acad Sci U S A 2017
93
31

IFITM3 restricts influenza A virus entry by blocking the formation of fusion pores following virus-endosome hemifusion.
Tanay M Desai, Mariana Marin, Christopher R Chin, George Savidis, Abraham L Brass, Gregory B Melikyan. PLoS Pathog 2014
190
27

Phenotypic properties of transmitted founder HIV-1.
Nicholas F Parrish, Feng Gao, Hui Li, Elena E Giorgi, Hannah J Barbian, Erica H Parrish, Lara Zajic, Shilpa S Iyer, Julie M Decker, Amit Kumar,[...]. Proc Natl Acad Sci U S A 2013
288
26

Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progression.
Netanya G Sandler, Steven E Bosinger, Jacob D Estes, Richard T R Zhu, Gregory K Tharp, Eli Boritz, Doron Levin, Sathi Wijeyesinghe, Krystelle Nganou Makamdop, Gregory Q del Prete,[...]. Nature 2014
327
24

Relative resistance of HIV-1 founder viruses to control by interferon-alpha.
Angharad E Fenton-May, Oliver Dibben, Tanja Emmerich, Haitao Ding, Katja Pfafferott, Marlen M Aasa-Chapman, Pierre Pellegrino, Ian Williams, Myron S Cohen, Feng Gao,[...]. Retrovirology 2013
143
24

SERINC3 and SERINC5 restrict HIV-1 infectivity and are counteracted by Nef.
Yoshiko Usami, Yuanfei Wu, Heinrich G Göttlinger. Nature 2015
260
24

Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus.
I-Chueh Huang, Charles C Bailey, Jessica L Weyer, Sheli R Radoshitzky, Michelle M Becker, Jessica J Chiang, Abraham L Brass, Asim A Ahmed, Xiaoli Chi, Lian Dong,[...]. PLoS Pathog 2011
408
24

The V3 Loop of HIV-1 Env Determines Viral Susceptibility to IFITM3 Impairment of Viral Infectivity.
Yimeng Wang, Qinghua Pan, Shilei Ding, Zhen Wang, Jingyou Yu, Andrés Finzi, Shan-Lu Liu, Chen Liang. J Virol 2017
36
66

The N-terminal region of IFITM3 modulates its antiviral activity by regulating IFITM3 cellular localization.
Rui Jia, Qinghua Pan, Shilei Ding, Liwei Rong, Shan-Lu Liu, Yunqi Geng, Wentao Qiao, Chen Liang. J Virol 2012
121
23

Human MX2 is an interferon-induced post-entry inhibitor of HIV-1 infection.
Caroline Goujon, Olivier Moncorgé, Hélène Bauby, Tomas Doyle, Christopher C Ward, Torsten Schaller, Stéphane Hué, Wendy S Barclay, Reiner Schulz, Michael H Malim. Nature 2013
389
22

HIV-1 Nef promotes infection by excluding SERINC5 from virion incorporation.
Annachiara Rosa, Ajit Chande, Serena Ziglio, Veronica De Sanctis, Roberto Bertorelli, Shih Lin Goh, Sean M McCauley, Anetta Nowosielska, Stylianos E Antonarakis, Jeremy Luban,[...]. Nature 2015
259
22

HIV-1 and interferons: who's interfering with whom?
Tomas Doyle, Caroline Goujon, Michael H Malim. Nat Rev Microbiol 2015
192
21

The antiviral effector IFITM3 disrupts intracellular cholesterol homeostasis to block viral entry.
Samad Amini-Bavil-Olyaee, Youn Jung Choi, Jun Han Lee, Mude Shi, I-Chueh Huang, Michael Farzan, Jae U Jung. Cell Host Microbe 2013
219
21

IFITM-Family Proteins: The Cell's First Line of Antiviral Defense.
Charles C Bailey, Guocai Zhong, I-Chueh Huang, Michael Farzan. Annu Rev Virol 2014
252
21

Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein.
Ann M Sheehy, Nathan C Gaddis, Jonathan D Choi, Michael H Malim. Nature 2002
20

Natural mutations in IFITM3 modulate post-translational regulation and toggle antiviral specificity.
Alex A Compton, Nicolas Roy, Françoise Porrot, Anne Billet, Nicoletta Casartelli, Jacob S Yount, Chen Liang, Olivier Schwartz. EMBO Rep 2016
63
31

The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys.
Matthew Stremlau, Christopher M Owens, Michel J Perron, Michael Kiessling, Patrick Autissier, Joseph Sodroski. Nature 2004
19

MX2 is an interferon-induced inhibitor of HIV-1 infection.
Melissa Kane, Shalini S Yadav, Julia Bitzegeio, Sebla B Kutluay, Trinity Zang, Sam J Wilson, John W Schoggins, Charles M Rice, Masahiro Yamashita, Theodora Hatziioannou,[...]. Nature 2013
337
19


SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx.
Nadine Laguette, Bijan Sobhian, Nicoletta Casartelli, Mathieu Ringeard, Christine Chable-Bessia, Emmanuel Ségéral, Ahmad Yatim, Stéphane Emiliani, Olivier Schwartz, Monsef Benkirane. Nature 2011
18

The CD225 domain of IFITM3 is required for both IFITM protein association and inhibition of influenza A virus and dengue virus replication.
Sinu P John, Christopher R Chin, Jill M Perreira, Eric M Feeley, Aaron M Aker, George Savidis, Sarah E Smith, Andrew E H Elia, Aaron R Everitt, Mehul Vora,[...]. J Virol 2013
121
18

IFITM3 restricts the morbidity and mortality associated with influenza.
Aaron R Everitt, Simon Clare, Thomas Pertel, Sinu P John, Rachael S Wash, Sarah E Smith, Christopher R Chin, Eric M Feeley, Jennifer S Sims, David J Adams,[...]. Nature 2012
510
18

A diverse range of gene products are effectors of the type I interferon antiviral response.
John W Schoggins, Sam J Wilson, Maryline Panis, Mary Y Murphy, Christopher T Jones, Paul Bieniasz, Charles M Rice. Nature 2011
18

The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein.
Nanette Van Damme, Daniel Goff, Chris Katsura, Rebecca L Jorgenson, Richard Mitchell, Marc C Johnson, Edward B Stephens, John Guatelli. Cell Host Microbe 2008
795
17

Interference with the production of infectious viral particles and bimodal inhibition of replication are broadly conserved antiviral properties of IFITMs.
Kevin Tartour, Xuan-Nhi Nguyen, Romain Appourchaux, Sonia Assil, Véronique Barateau, Louis-Marie Bloyet, Julien Burlaud Gaillard, Marie-Pierre Confort, Beatriz Escudero-Perez, Henri Gruffat,[...]. PLoS Pathog 2017
38
44

Heterosexual Transmission of Subtype C HIV-1 Selects Consensus-Like Variants without Increased Replicative Capacity or Interferon-α Resistance.
Martin J Deymier, Zachary Ende, Angharad E Fenton-May, Dario A Dilernia, William Kilembe, Susan A Allen, Persephone Borrow, Eric Hunter. PLoS Pathog 2015
58
27

Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection.
Brandon F Keele, Elena E Giorgi, Jesus F Salazar-Gonzalez, Julie M Decker, Kimmy T Pham, Maria G Salazar, Chuanxi Sun, Truman Grayson, Shuyi Wang, Hui Li,[...]. Proc Natl Acad Sci U S A 2008
16

Guanylate Binding Protein (GBP) 5 Is an Interferon-Inducible Inhibitor of HIV-1 Infectivity.
Christian Krapp, Dominik Hotter, Ali Gawanbacht, Paul J McLaren, Silvia F Kluge, Christina M Stürzel, Katharina Mack, Elisabeth Reith, Susanne Engelhart, Angela Ciuffi,[...]. Cell Host Microbe 2016
131
16

Ifitm3 limits the severity of acute influenza in mice.
Charles C Bailey, I-Chueh Huang, Christina Kam, Michael Farzan. PLoS Pathog 2012
160
16


Amphotericin B increases influenza A virus infection by preventing IFITM3-mediated restriction.
Tsai-Yu Lin, Christopher R Chin, Aaron R Everitt, Simon Clare, Jill M Perreira, George Savidis, Aaron M Aker, Sinu P John, David Sarlah, Erick M Carreira,[...]. Cell Rep 2013
73
21

IFITM3 inhibits influenza A virus infection by preventing cytosolic entry.
Eric M Feeley, Jennifer S Sims, Sinu P John, Christopher R Chin, Thomas Pertel, Li-Mei Chen, Gaurav D Gaiha, Bethany J Ryan, Ruben O Donis, Stephen J Elledge,[...]. PLoS Pathog 2011
259
15

IFITMs restrict the replication of multiple pathogenic viruses.
Jill M Perreira, Christopher R Chin, Eric M Feeley, Abraham L Brass. J Mol Biol 2013
151
15

Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection.
Jesus F Salazar-Gonzalez, Maria G Salazar, Brandon F Keele, Gerald H Learn, Elena E Giorgi, Hui Li, Julie M Decker, Shuyi Wang, Joshua Baalwa, Matthias H Kraus,[...]. J Exp Med 2009
570
14

Identification of an endocytic signal essential for the antiviral action of IFITM3.
Rui Jia, Fengwen Xu, Jin Qian, Yunfang Yao, Chunhui Miao, Yi-Min Zheng, Shan-Lu Liu, Fei Guo, Yunqi Geng, Wentao Qiao,[...]. Cell Microbiol 2014
87
16

Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein.
Kasia Hrecka, Caili Hao, Magda Gierszewska, Selene K Swanson, Malgorzata Kesik-Brodacka, Smita Srivastava, Laurence Florens, Michael P Washburn, Jacek Skowronski. Nature 2011
859
13

Codon-usage-based inhibition of HIV protein synthesis by human schlafen 11.
Manqing Li, Elaine Kao, Xia Gao, Hilary Sandig, Kirsten Limmer, Mariana Pavon-Eternod, Thomas E Jones, Sebastien Landry, Tao Pan, Matthew D Weitzman,[...]. Nature 2012
207
13

Primate lentiviruses are differentially inhibited by interferon-induced transmembrane proteins.
Jin Qian, Yann Le Duff, Yimeng Wang, Qinghua Pan, Shilei Ding, Yi-Min Zheng, Shan-Lu Liu, Chen Liang. Virology 2015
31
41

Interferon-induced cell membrane proteins, IFITM3 and tetherin, inhibit vesicular stomatitis virus infection via distinct mechanisms.
Jessica M Weidner, Dong Jiang, Xiao-Ben Pan, Jinhong Chang, Timothy M Block, Ju-Tao Guo. J Virol 2010
224
13

Δ20 IFITM2 differentially restricts X4 and R5 HIV-1.
Wan-Lin Wu, Christopher Robert Grotefend, Ming-Ting Tsai, Yi-Ling Wang, Vladimir Radic, Hyungjin Eoh, I-Chueh Huang. Proc Natl Acad Sci U S A 2017
21
61

Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections.
Andrea R Stacey, Philip J Norris, Li Qin, Elizabeth A Haygreen, Elizabeth Taylor, John Heitman, Mila Lebedeva, Allan DeCamp, Dongfeng Li, Douglas Grove,[...]. J Virol 2009
515
12

Bottlenecks in HIV-1 transmission: insights from the study of founder viruses.
Sarah B Joseph, Ronald Swanstrom, Angela D M Kashuba, Myron S Cohen. Nat Rev Microbiol 2015
119
12

MARCH8 inhibits HIV-1 infection by reducing virion incorporation of envelope glycoproteins.
Takuya Tada, Yanzhao Zhang, Takayoshi Koyama, Minoru Tobiume, Yasuko Tsunetsugu-Yokota, Shoji Yamaoka, Hideaki Fujita, Kenzo Tokunaga. Nat Med 2015
75
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.